Jean-Pierre Lindenmayer, MD

Article

Conclusions: Antipsychotic-Induced Weight Gain and Metabolic Abnormalities

May 1, 2004

Article

Monitoring Metabolic Side Effects

May 1, 2004

Article

The Impact of Atypical Antipsychotics on Weight Gain

May 1, 2004

Original Research

Effects of Atypical Antipsychotics on the Syndromal Profile in Treatment-Resistant Schizophrenia

April 1, 2004

Original Research

Prolactin Levels in Schizophrenia and Schizoaffective Disorder Patients Treated With Clozapine, Olanzapine, Risperidone, or Haloperidol

January 1, 2004

Original Research

Olanzapine in Refractory Schizophrenia After Failure of Typical or Atypical Antipsychotic Treatment: An Open-Label Switch Study

October 1, 2002

Article

Hyperglycemia Associated With the Use of Atypical Antipsychotics

January 9, 2001

Article

The Pathophysiology of Agitation

December 30, 2000

Original Research

Use of Sodium Valproate in Violent and Aggressive Behaviors: A Critical Review

July 31, 2000

Original Research

Clinical and Neurocognitive Effects of Clozapine and Risperidone in Treatment-Refractory Schizophrenic Patients: A Prospective Study

October 15, 1998

Letter to the Editor

Olanzapine-Induced Manic-Like Syndrome

June 15, 1998